Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -27.97 | -16.22 |
PEG Ratio (TTM) | -0.85 | -1.41 |
P/S Ratio (TTM) | 2,671.05 | 48.82 |
P/B Ratio (TTM) | 5.83 | 21.13 |
P/FCF Ratio (TTM) | -28.38 | 9.38 |
Price to 5YR AVG Earnings Ratio | N/A | -0.21 |
Price to 5YR AVG FCF Ratio | N/A | -7.10 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -20.19% | -3.10% |
ROE (TTM) | -19.76% | 24.21% |
Net Profit Margin (TTM) | -9,536.81% | -1,069.78% |
ROIC 5YR AVG | N/A | 16.50% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -0.39% | -701.94% | N/A |
Revenue | -50.00% | -48.41% | N/A |
Net Income | 0.26% | -591.03% | N/A |
Cash Flow | 10.01% | -91.27% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 32.78 | 5.75 |
Quick Ratio (TTM) | 32.78 | 5.47 |
D/E Ratio (TTM) | 0.00 | -15.13 |
Interest Coverage (TTM) | -15.12 | 3.59 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 13.47 |
LTL to 5YR AVG FCF | N/A | 0.20 |
Shares Outstanding Growth 5YR AVG | N/A | 118.86% |